Nektar Therapeutics stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients.
Yahoo
Skip to navigation
Skip to main content
Skip to right column
Nektar Posted Promising Alopecia Results. Here's Why It Took A 22% Beating. ·
Investor's Business Daily
